<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6864947</article-id><article-id pub-id-type="publisher-id">2659</article-id><article-id pub-id-type="doi">10.1186/s13054-019-2659-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Translational medicine between human and veterinary emergency and critical care medicine: a story meant to have a happy ending</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>F&#x000e9;lix</surname><given-names>Nuno M.</given-names></name><address><email>nuno.felixgrey@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1647-1002</contrib-id><name><surname>Gommeren</surname><given-names>K.</given-names></name><address><email>krisjeg@hotmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Boysen</surname><given-names>S.</given-names></name><address><email>srboysen@ucalgary.ca</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Departamento de Pediatria Hospital de Santar&#x000e9;m, Departamento de Pediatria Hospital de Santa Maria, Centro Hospitalar Universit&#x000e1;rio Lisboa Norte, Lisbon, Portugal </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0805 7253</institution-id><institution-id institution-id-type="GRID">grid.4861.b</institution-id><institution>Faculty of Veterinary Medicine, </institution><institution>University of Li&#x000e8;ge, </institution></institution-wrap>Li&#x000e8;ge, Belgium </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 7697</institution-id><institution-id institution-id-type="GRID">grid.22072.35</institution-id><institution>Faculty of Veterinary Medicine, </institution><institution>University of Calgary, </institution></institution-wrap>Calgary, Canada </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>23</volume><elocation-id>361</elocation-id><history><date date-type="received"><day>6</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">&#x0201c;Despite several fluid boluses and vasopressor support, mean arterial pressure hovered around 50&#x02009;mmHg, lactate levels increased and ScvO<sub>2</sub> remained at 55%. The patient was in septic shock. Should inotropic drugs be started? Physiologic steroids? Cardiac ultrasound &#x02026;?&#x0201d;</p><p id="Par2">To many emergency and critical care (ECC) physicians, this is a daily routine. Few imagine this patient being a dog or cat. However, small animal intensive care units (ICUs) exist. Human and veterinary emergency and critical care (HECC and VECC) share attitudes and values, providing opportunities for the development of both professions.</p><p id="Par3">Advancements in ECC rely on animal experiments [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], particularly rodent models due to large litter sizes, short generation time, relatively low maintenance requirements, and the ease of introducing genetic modification in these species [<xref ref-type="bibr" rid="CR2">2</xref>]. These characteristics make translational medicine from rodent-based models to humans fundamental to understanding the pathologic mechanisms behind many human ECC conditions [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par4">However, the translation of rodent-based research to clinical practice has been questioned for several reasons, including the use of young, single-sex, genetically modified, healthy (or limited comorbidities), inbred subjects, kept in homogeneous, regulated environments [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Recent studies have also suggested that rodents and humans may differ more in their genetic response to acute injury than originally believed [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par5">Sheep, pigs, rabbits, and non-human primates have also been used in ECC research [<xref ref-type="bibr" rid="CR4">4</xref>]. Proposed advantages of these species include their larger size, allowing advanced monitoring similar to what exists in human ICUs, ability to create predefined comorbidities, and the fact these species have similar hemodynamic and cardiovascular responses to humans. However, large animal models are relatively expensive, have limited immunologic markers available in some species (e.g., sheep), and share similar limitations to rodent models (e.g., single-sex experiments) [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par6">Although valuable in preclinical research, a gap still exists between animal models and the clinical human ECC setting [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In our opinion, this gap can be partially filled by studying companion animals [<xref ref-type="bibr" rid="CR5">5</xref>] as a model for ECC human diseases, for several reasons.</p><p id="Par7">First, most HECC scenarios (e.g., sepsis) also exist in companion animals, with similar pathophysiologic mechanisms. The similarity is especially remarkable in pediatric patients, which are less afflicted by lifestyle choices like smoking and alcoholism (not observed in companion animals) and complications of chronic diseases (e.g., diabetic nephropathy). Dogs and cats, having shorter life spans, rarely manifest such complications.</p><p id="Par8">Second, companion animals have complex genetic, environmental, and physiological variation, which in many cases are similar or even shared with humans [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par9">Third, current ECC management of critically ill dogs and cats is similar to humans. Veterinarians have access to advanced diagnostics including molecular testing and advanced imaging. In VECC, capnography, invasive hemodynamic, and ICP monitoring are performed, and sidestream dark-field imaging and tissue oxygen saturation have been used clinically. Advanced therapeutic modalities in VECC include ventilation, interventional radiology, advanced hemodynamic support, transfusion therapy, continuous renal replacement therapy, and cardiac bypass, among others.</p><p id="Par10">Fourth, current challenges faced by VECC are similar to those in HECC: specific markers of sepsis, synthetic colloids in septic patients, identifying volume-responsive patients, mechanical ventilation strategies, antibiotic selection and treatment duration, and transfusion strategies in trauma, just to name a few.</p><p id="Par11">Therefore, we believe cooperation between HECC and VECC can provide a bidirectional, synergistic pathway, with benefits for both by the following:
<list list-type="bullet"><list-item><p id="Par12"><italic>Improving the knowledge of critical disease pathophysiology.</italic> This has been reported for spinal cord injury [<xref ref-type="bibr" rid="CR7">7</xref>], epilepsy [<xref ref-type="bibr" rid="CR8">8</xref>], cardiomyopathies [<xref ref-type="bibr" rid="CR9">9</xref>], asthma [<xref ref-type="bibr" rid="CR10">10</xref>], and cancer [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In oncology, the Comparative Oncology Genomics Consortium, within the National Cancer Institute and the Purdue Comparative Oncology Program (PCOP) [<xref ref-type="bibr" rid="CR11">11</xref>], have discovered new aspects of carcinogenesis and cancer biology and facilitated the development of new diagnostics and therapeutics [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p></list-item><list-item><p id="Par13"><italic>Bridging preclinical data and human clinical trials, to evaluate safety and efficacy of new treatments.</italic> This is one of the strongest arguments to support HECC and VECC collaboration. An example was the canine trial of ibrutinib in naturally occurring B cell malignancy that accelerated its FDA approval for human mantle cell lymphoma [<xref ref-type="bibr" rid="CR12">12</xref>].</p></list-item><list-item><p id="Par14"><italic>Providing new therapeutic alternatives.</italic> Cyclosporine-based ophthalmic emulsion for the treatment of keratoconjunctivitis sicca was first reported by a veterinary ophthalmologist [<xref ref-type="bibr" rid="CR13">13</xref>].</p></list-item></list></p><sec id="Sec1"><title>Limitations</title><p id="Par15">Limitations for translating VECC-generated data to HECC do exist. Genetic, anatomical, and physiological differences between species remain a limitation of companion animal models. For example, the highly contractile nature of the canine spleen, which can store and auto-transfuse a larger blood volume than the human spleen, plays a greater role in the response to hemorrhage than humans [<xref ref-type="bibr" rid="CR4">4</xref>]. In addition, dogs and cats may be less applicable than sheep or pigs when size-related variables are important research considerations. Additionally, because costs are primarily owner driven in VECC (pet insurance is not readily available worldwide), economic factors play a significant role in medical decision-making. Moreover, euthanasia is ethically acceptable for animals in specific circumstances. These factors may limit the intensity and/or duration of ECC treatment in VECC, although this will more heavily impact the translation of HECC data to VECC than the reverse.</p></sec><sec id="Sec2"><title>Concluding remarks</title><p id="Par16">Board-certified specialization in VECC exists through the American and European Colleges of Veterinary Emergency and Critical Care (ACVECC and ECVECC). Residency programs are available in many parts of the world, and international collaborations are becoming a commonplace. Consensus guidelines regarding several subjects are now available (e.g., cardiopulmonary resuscitation) [<xref ref-type="bibr" rid="CR14">14</xref>] or in development.</p><p id="Par17">Interestingly, the collaboration between HECC and VECC has already begun. During the 2010 Multi-Disciplinary Review/Post-Graduate Review in San Diego, human trauma surgeons, VECC specialists, and translational medicine scientists discussed the use of naturally occurring canine trauma as a model to human trauma (Spontaneous Trauma in Animals Team). This led the ACVECC Veterinary Committee on Trauma to create a clinical research infrastructure to enhance uniform delivery of care and permit large-scale clinical trials in canine and feline trauma patients [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par18">In conclusion, we believe the use of companion animals to model human ECC can complement current available preclinical animal models, with benefits to all species. To achieve this, VECC and HECC should increase and promote the collaboration which already exists. We just have to say yes and seize the opportunity.</p></sec></body><back><fn-group><fn><p>Supported by the Presidents of the European and American College of Veterinary Emergency and Critical Care (ECVECC and ACVECC)</p></fn><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The presidents of the American and European Colleges of Veterinary Emergency and Critical Care for taking the time to read, comment on, and provide support for the article.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>NMF drafted/revised the manuscript. KG drafted/revised the manuscript. SRB drafted/revised the manuscript and accepted the responsibility of final approval. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Not applicable</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not applicable</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par19">Not applicable</p></notes><notes><title>Consent for publication</title><p id="Par20">Not applicable</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par21">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e8;ne</surname><given-names>F</given-names></name><name><surname>Ait-Oufella</surname><given-names>H</given-names></name><name><surname>Taccone</surname><given-names>FS</given-names></name><name><surname>Monneret</surname><given-names>G</given-names></name><name><surname>Sharshar</surname><given-names>T</given-names></name><name><surname>Tamion</surname><given-names>F</given-names></name><name><surname>Mira</surname><given-names>JP</given-names></name></person-group><article-title>Commission de Recherche Translationnelle de la Soci&#x000e9;t&#x000e9; de R&#x000e9;animation de Langue Fran&#x000e7;aise (SRLF). Insights and limits of translational research in critical care medicine</article-title><source>Ann Intensive Care</source><year>2015</year><volume>5</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/s13613-015-0050-3</pub-id><?supplied-pmid 25977834?><pub-id pub-id-type="pmid">25977834</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stortz</surname><given-names>JA</given-names></name><name><surname>Raymond</surname><given-names>SL</given-names></name><name><surname>Mira</surname><given-names>JC</given-names></name><name><surname>Moldawer</surname><given-names>LL</given-names></name><name><surname>Mohr</surname><given-names>AM</given-names></name><name><surname>Efron</surname><given-names>PA</given-names></name></person-group><article-title>Murine models of sepsis and trauma: can we bridge the gap?</article-title><source>ILAR J</source><year>2017</year><volume>58</volume><issue>1</issue><fpage>90</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1093/ilar/ilx007</pub-id><pub-id pub-id-type="pmid">28444204</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osuchowski</surname><given-names>MF</given-names></name><name><surname>Remick</surname><given-names>DG</given-names></name><name><surname>Lederer</surname><given-names>JA</given-names></name><name><surname>Lang</surname><given-names>CH</given-names></name><name><surname>Aasen</surname><given-names>AO</given-names></name><name><surname>Aibiki</surname><given-names>M</given-names></name><name><surname>Azevedo</surname><given-names>LC</given-names></name><name><surname>Bahrami</surname><given-names>S</given-names></name><name><surname>Boros</surname><given-names>M</given-names></name><name><surname>Cooney</surname><given-names>R</given-names></name><name><surname>Cuzzocrea</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Junger</surname><given-names>WG</given-names></name><name><surname>Hirasawa</surname><given-names>H</given-names></name><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Li</surname><given-names>XA</given-names></name><name><surname>Radermacher</surname><given-names>P</given-names></name><name><surname>Redl</surname><given-names>H</given-names></name><name><surname>Salomao</surname><given-names>R</given-names></name><name><surname>Soebandrio</surname><given-names>A</given-names></name><name><surname>Thiemermann</surname><given-names>C</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Ward</surname><given-names>P</given-names></name><name><surname>Yao</surname><given-names>YM</given-names></name><name><surname>Yu</surname><given-names>HP</given-names></name><name><surname>Zingarelli</surname><given-names>B</given-names></name><name><surname>Chaudry</surname><given-names>IH</given-names></name></person-group><article-title>Abandon the mouse research ship? Not just yet!</article-title><source>Shock</source><year>2014</year><volume>41</volume><issue>6</issue><fpage>463</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1097/SHK.0000000000000153</pub-id><pub-id pub-id-type="pmid">24569509</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>CJ</given-names></name></person-group><article-title>Preclinical models of traumatic, hemorrhagic shock</article-title><source>Shock</source><year>2005</year><volume>24</volume><issue>1</issue><fpage>23</fpage><lpage>32</lpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kol</surname><given-names>A</given-names></name><name><surname>Arzi</surname><given-names>B</given-names></name><name><surname>Athanasiou</surname><given-names>KA</given-names></name><name><surname>Farmer</surname><given-names>DL</given-names></name><name><surname>Nolta</surname><given-names>JA</given-names></name><name><surname>Rebhun</surname><given-names>RB</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Griffiths</surname><given-names>LG</given-names></name><name><surname>Verstraete</surname><given-names>FJ</given-names></name><name><surname>Murphy</surname><given-names>CJ</given-names></name><name><surname>Borjesson</surname><given-names>DL</given-names></name></person-group><article-title>Companion animals: translational scientist&#x02019;s new best friends</article-title><source>Sci Transl Med</source><year>2015</year><volume>7</volume><issue>308</issue><fpage>308ps21</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aaa9116</pub-id><?supplied-pmid 26446953?><pub-id pub-id-type="pmid">26446953</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christopher</surname><given-names>MM</given-names></name></person-group><article-title>One health, one literature: weaving together veterinary and medical research</article-title><source>Sci Transl Med</source><year>2015</year><volume>7</volume><fpage>303fs36</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aab0215</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>SA</given-names></name><name><surname>Zidan</surname><given-names>N</given-names></name><name><surname>Spitzbarth</surname><given-names>I</given-names></name><name><surname>Nout-Lomas</surname><given-names>YS</given-names></name><name><surname>Granger</surname><given-names>N</given-names></name><name><surname>da Costa</surname><given-names>RC</given-names></name><name><surname>Levine</surname><given-names>JM</given-names></name><name><surname>Jeffery</surname><given-names>ND</given-names></name><name><surname>Stein</surname><given-names>VM</given-names></name><name><surname>Tipold</surname><given-names>A</given-names></name><name><surname>Olby</surname><given-names>NJ</given-names></name></person-group><article-title>Development of an International Canine Spinal Cord Injury observational registry: a collaborative data-sharing network to optimize translational studies of SCI</article-title><source>Spinal Cord</source><year>2018</year><volume>56</volume><issue>7</issue><fpage>656</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1038/s41393-018-0145-4</pub-id><pub-id pub-id-type="pmid">29795173</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potschka</surname><given-names>H</given-names></name><name><surname>Fischer</surname><given-names>A</given-names></name><name><surname>von R&#x000fc;den</surname><given-names>EL</given-names></name><name><surname>H&#x000fc;lsmeyer</surname><given-names>V</given-names></name><name><surname>Baumg&#x000e4;rtner</surname><given-names>W</given-names></name></person-group><article-title>Canine epilepsy as a translational model?</article-title><source>Epilepsia</source><year>2013</year><volume>54</volume><issue>4</issue><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1111/epi.12138</pub-id><pub-id pub-id-type="pmid">23506100</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>PR</given-names></name><name><surname>Basso</surname><given-names>C</given-names></name><name><surname>Thiene</surname><given-names>G</given-names></name><name><surname>Maron</surname><given-names>BJ</given-names></name></person-group><article-title>Spontaneously occurring restrictive nonhypertrophied cardiomyopathy in domestic cats: a new animal model of human disease</article-title><source>Cardiovasc Pathol</source><year>2014</year><volume>23</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.carpath.2013.08.001</pub-id><pub-id pub-id-type="pmid">24035181</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershwin</surname><given-names>LJ</given-names></name></person-group><article-title>Comparative immunology of allergic responses</article-title><source>Annu Rev Anim Biosci</source><year>2015</year><volume>3</volume><fpage>327</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1146/annurev-animal-022114-110930</pub-id><pub-id pub-id-type="pmid">25422854</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>JA</given-names></name></person-group><article-title>Researchers turn to canine clinical trials to advance cancer therapies</article-title><source>JAMA</source><year>2016</year><volume>315</volume><issue>15</issue><fpage>1550</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0082</pub-id><pub-id pub-id-type="pmid">27027696</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honigberg</surname><given-names>LA</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Sirisawad</surname><given-names>M</given-names></name><name><surname>Verner</surname><given-names>E</given-names></name><name><surname>Loury</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Thamm</surname><given-names>DH</given-names></name><name><surname>Miller</surname><given-names>RA</given-names></name><name><surname>Buggy</surname><given-names>JJ</given-names></name></person-group><article-title>The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>13075</fpage><lpage>13080</lpage><pub-id pub-id-type="doi">10.1073/pnas.1004594107</pub-id><pub-id pub-id-type="pmid">20615965</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaswan</surname><given-names>RL</given-names></name><name><surname>Salisbury</surname><given-names>MA</given-names></name><name><surname>Ward</surname><given-names>DA</given-names></name></person-group><article-title>Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops</article-title><source>Arch Ophthalmol</source><year>1989</year><volume>107</volume><fpage>1210</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1001/archopht.1989.01070020276038</pub-id><pub-id pub-id-type="pmid">2757551</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>Daniel J.</given-names></name><name><surname>Boller</surname><given-names>Manuel</given-names></name><name><surname>Brainard</surname><given-names>Benjamin M.</given-names></name><name><surname>Haskins</surname><given-names>Steven C.</given-names></name><name><surname>Hopper</surname><given-names>Kate</given-names></name><name><surname>McMichael</surname><given-names>Maureen A.</given-names></name><name><surname>Rozanski</surname><given-names>Elizabeth A.</given-names></name><name><surname>Rush</surname><given-names>John E.</given-names></name><name><surname>Smarick</surname><given-names>Sean D.</given-names></name></person-group><article-title>RECOVER evidence and knowledge gap analysis on veterinary CPR. Part 7: Clinical guidelines</article-title><source>Journal of Veterinary Emergency and Critical Care</source><year>2012</year><volume>22</volume><issue>s1</issue><fpage>S102</fpage><lpage>S131</lpage><pub-id pub-id-type="doi">10.1111/j.1476-4431.2012.00757.x</pub-id><pub-id pub-id-type="pmid">22676281</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>KE</given-names></name><name><surname>Sharp</surname><given-names>CR</given-names></name><name><surname>Adams</surname><given-names>CR</given-names></name><name><surname>Beilman</surname><given-names>G</given-names></name></person-group><article-title>A novel trauma model: naturally occurring canine trauma</article-title><source>Shock</source><year>2014</year><volume>41</volume><issue>1</issue><fpage>25</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1097/SHK.0000000000000058</pub-id><pub-id pub-id-type="pmid">24089005</pub-id></element-citation></ref></ref-list></back></article>